•Identified
the Ireα-Xbp1 pathway as a modulator of cyst growth
•Inhibition
of this pathway at the genetic level slows down disease progression in
orthologous animal models through specific apoptosis of mutant cells
•Generated
a pre-clinical efficacy package around a novel use for an Ireα inhibitor
previously tested in human trials